Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Are CPGs Changing Practice?

Mar 1, 2024/Feature

CPGs are meant to optimize patient care by providing PTs and PTAs with recommended care options — as long as clinicians follow them.

New Policy Priorities Celebrate Wins but Fight for More

Mar 1, 2025/Feature

APTA's updated public policy priorities reflect past progress while focusing on the need for increased payment.

MIPS Value Pathways

Feb 27, 2024/Resource

MIPS Value Pathways, or MVPs, are a voluntary reporting option that clinicians can participate in as an alternative to traditional MIPS or an APM Performance Pathway.

Researcher Spotlight

Mar 1, 2024/Column

Linda Resnik, PT, PhD, FAPTA, leads the Center for Health Services Training and Research.

Mandatory Versus Voluntary Participation Options

Feb 27, 2024/Resource

CMS has established a low-volume threshold to determine if an individual PT or a physical therapy private practice can be excluded from mandatory participation in MIPS.

MIPS Performance Reporting Requirements

Feb 27, 2024/Resource

MIPS performance is measured across four categories – cost, quality, improvement activities, and promoting interoperability.

It's OK to Say, 'I Don't Know': Career Wisdom for New PTs and PTAs

Jun 1, 2026/Article

Seasoned clinicians reflect on their early years to share the lessons they wish they'd learned sooner.

Neuroplasticity: The Science, the Spark, and the Everyday Work of Physical Therapy

Aug 1, 2026/Feature

Better brain, better outcomes. Why neuroplasticity matters in every physical therapy session.

The Power of Student Advocacy

Apr 1, 2026/Feature

Meet the next generation of advocates who are learning that shaping the future of physical therapy starts with speaking up now.

Defining Moment | From Capitol Hill to the Clinic Curb

Jun 1, 2026/Column

One PT learned that advocacy doesn't always take place in Washington, D.C. Sometimes, it starts on the sidewalk outside your clinic.